Thyssen'sche Handelsgesellschaft has acquired h/p/cosmos sports & medical GmbH
Thyssen’sche Handelsgesellschaft mbH (THG), a German strategic holding company, has acquired a majority stake in h/p/cosmos sports & medical GmbH. Founder and former sole shareholder Franz Harrer, who built h/p/cosmos into a global leader in niche medical and sports diagnostics equipment, remains invested as a minority partner. THG will support the company’s international growth and innovation plans, while the existing management team continues to run the business.
THG is a traditional German family office with a long-term investment approach focused on value preservation and sustainable growth.
h/p/cosmos is a leading German manufacturer of high-performance treadmill systems and related technologies for diagnostics, rehabilitation and elite sports. Founded in 1988 and headquartered in Traunstein, the company generates around US$20 million (€17 million) in annual revenue, exports approximately 80 percent of its products and serves customers in more than 90 countries worldwide. Its portfolio includes advanced treadmills, ergometers, gait trainers and integrated systems for ergometry, rehabilitation, cardiopulmonary and performance diagnostics, biomechanics and sports science. As a technology pioneer, h/p/cosmos has significantly shaped the global development of treadmill systems through innovations such as the Virtual Split-Belt, perturbation functions, the MDR-certified gaitway 3d treadmill and the patented Robowalk gait trainer.
Oaklins’ team in Germany acted as the exclusive buy-side advisor to THG in the acquisition of h/p/cosmos.
Sprechen Sie mit dem Deal Team
Transaktionen
Valmiermuižas Alus has been acquired by Cēsu Alus
Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.
Mehr erfahrenDie Lindenhofgruppe veräussert ihre Mehrheitsbeteiligung an der LabPoint an Affidea Switzerland
Die LabPoint Medizinische Laboratorien AG wurde von Affidea Switzerland AG übernommen. Mit Affidea hat die Lindenhofgruppe AG einen starken strategischen Partner für die Weiterentwicklung der LabPoint gewonnen. Die Lindenhofgruppe bleibt bedeutende Aktionärin und Grosskundin des Unternehmens. Damit schafft sie die Grundlage für eine nachhaltige Weiterentwicklung von LabPoint unter einer neuen Ankeraktionärin. LabPoint soll ihre Position in der Labordiagnostik weiter stärken und gezielt ausbauen.
Mehr erfahrenArmira has signed an agreement to acquire a majority stake in Viabus
Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.
Mehr erfahren